We present a patient with a drug-induced liver injury with autoimmune features as a result of infliximab therapy for ulcerative colitis. This is a rare but serious side effect in patients receiving this treatment which clinicians should consider in the event of liver function test derangement.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603518 | PMC |
| http://dx.doi.org/10.1136/bcr-2022-254272 | DOI Listing |
Publication Analysis
Top Keywords
drug-induced liver
8
liver injury
8
injury autoimmune
8
autoimmune features
8
ulcerative colitis
8
features secondary
4
secondary infliximab
4
infliximab ulcerative
4
colitis patient
4
patient drug-induced
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!